Mesoblast Ltd (MESO)
7.495
+0.20
(+2.81%)
USD |
NASDAQ |
May 03, 16:00
7.495
0.00 (0.00%)
After-Hours: 20:00
Mesoblast Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 778.41M |
| May 01, 2024 | 770.29M |
| April 30, 2024 | 708.39M |
| April 29, 2024 | 759.13M |
| April 26, 2024 | 671.85M |
| April 25, 2024 | 662.72M |
| April 24, 2024 | 669.82M |
| April 23, 2024 | 647.50M |
| April 22, 2024 | 599.80M |
| April 19, 2024 | 567.33M |
| April 18, 2024 | 557.18M |
| April 17, 2024 | 547.03M |
| April 16, 2024 | 514.56M |
| April 15, 2024 | 563.27M |
| April 12, 2024 | 583.57M |
| April 11, 2024 | 620.10M |
| April 10, 2024 | 627.20M |
| April 09, 2024 | 632.28M |
| April 08, 2024 | 676.93M |
| April 05, 2024 | 627.20M |
| April 04, 2024 | 636.33M |
| April 03, 2024 | 679.97M |
| April 02, 2024 | 707.37M |
| April 01, 2024 | 655.62M |
| March 28, 2024 | 547.03M |
| Date | Value |
|---|---|
| March 27, 2024 | 392.78M |
| March 26, 2024 | 437.43M |
| March 25, 2024 | 261.87M |
| March 22, 2024 | 257.81M |
| March 21, 2024 | 267.96M |
| March 20, 2024 | 273.04M |
| March 19, 2024 | 271.01M |
| March 18, 2024 | 273.04M |
| March 15, 2024 | 285.21M |
| March 14, 2024 | 286.23M |
| March 13, 2024 | 286.23M |
| March 12, 2024 | 308.55M |
| March 11, 2024 | 308.55M |
| March 08, 2024 | 256.80M |
| March 07, 2024 | 261.87M |
| March 06, 2024 | 251.88M |
| March 05, 2024 | 247.67M |
| March 04, 2024 | 246.65M |
| March 01, 2024 | 245.64M |
| February 29, 2024 | 238.53M |
| February 28, 2024 | 250.71M |
| February 27, 2024 | 248.68M |
| February 26, 2024 | 246.45M |
| February 23, 2024 | 250.71M |
| February 22, 2024 | 247.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.46M
Minimum
Dec 11 2023
2.403B
Maximum
Aug 17 2020
779.52M
Average
654.62M
Median
Enterprise Value Benchmarks
| Immuron Ltd | 3.279M |
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 5.265M |
| Immutep Ltd | -- |
| Opthea Ltd | 118.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.92M |
| Revenue (Quarterly) | 2.139M |
| Total Expenses (Quarterly) | 20.88M |
| EPS Diluted (Quarterly) | 77.55 |